Out of 28 antibiotics in late stages of clinical development, only two have both access and stewardship plans in place
Four companies move to decouple antibiotic sales volumes from sales agents’ bonuses
Nearly half of companies with products on the market are involved in AMR surveillance
Eight companies are setting limits on antibiotic wastewater discharge
Antimicrobial portfolios: what medicines are on the market?
View our detailed overview of each company’s performance